Dataset Information


ECD4-Ig promotes ADCC activity of sera from HIV-1-infected patients.

ABSTRACT: Antibody-dependent cell-mediated cytotoxity (ADCC) can eliminate HIV-1 infected cells, and may help reduce the reservoir of latent virus in infected patients. Sera of HIV-1 positive individuals include a number of antibodies that recognize epitopes usually occluded on HIV-1 envelope glycoprotein (Env) trimers. We have recently described eCD4-Ig, a potent and exceptionally broad inhibitor of HIV-1 entry that can be used to protect rhesus macaques from multiple high-dose challenges with simian-human immunodeficiency virus AD8 (SHIV-AD8). Here we show that eCD4-Ig bearing an IgG1 Fc domain (eCD4-IgG1) can mediate efficient ADCC activity against HIV-1 isolates with differing tropisms, and that it does so at least 10-fold more efficiently than CD4-Ig, even when more CD4-Ig molecules bound cell surface-expressed Env. An ADCC-inactive IgG2 form of eCD4-Ig (eCD4-IgG2) exposes V3-loop and CD4-induced epitopes on cell-expressed trimers, and renders HIV-1-infected cells susceptible to ADCC mediated by antibodies of these classes. Moreover, eCD4-IgG2, but not IgG2 forms of the broadly neutralizing antibodies VRC01 and 10-1074, enhances the ADCC activities of serum antibodies from patients by 100-fold, and significantly enhanced killing of two latently infected T-cell lines reactivated by vorinostat or TNF?. Thus eCD4-Ig is qualitatively different from CD4-Ig or neutralizing antibodies in its ability to mediate ADCC, and it may be uniquely useful in treating HIV-1 infection or reducing the reservoir of latently infected cells.

SUBMITTER: Davis-Gardner ME 

PROVIDER: S-EPMC5749896 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4352131 | BioStudies
2019-01-01 | S-EPMC6403482 | BioStudies
2019-01-01 | S-EPMC6600210 | BioStudies
2016-01-01 | S-EPMC4733999 | BioStudies
2019-01-01 | S-EPMC6716512 | BioStudies
2019-01-01 | S-EPMC6384058 | BioStudies
2015-01-01 | S-EPMC4453581 | BioStudies
2019-01-01 | S-EPMC6498039 | BioStudies
2017-01-01 | S-EPMC5571245 | BioStudies
2015-01-01 | S-EPMC4301108 | BioStudies